NIH-funded research R01 grant

Understanding the genetic causes of Prader-Willi syndrome

Official title: Molecular underpinnings of Prader-Willi syndrome

Funded at University of Connecticut Sch of Med/dnt · NIH-10662498 · Data updated 2026-11-12

This study is looking at how certain genes related to Prader-Willi syndrome work, especially a group called SNORD116, to see if turning on the right genes can help improve brain function and find new ways to treat the condition.

More Prader-Willi Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Sch of Med/dnt
NIH-funded
Lab location1 site (Farmington, United States)
Project startSeptember 9, 2019
Project endJune 30, 2025
Funding year2023
Award (this year)$580,252
NIH project number5R01HD099975-05
Project IDNIH-10662498 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Prader-Willi syndrome.

Less likely to help

Patients without Prader-Willi syndrome or those with other unrelated genetic disorders may not benefit from this research.

What this research studies

This research investigates the genetic mechanisms behind Prader-Willi syndrome (PWS), a disorder caused by the loss of specific genes on chromosome 15. The study focuses on a cluster of small nucleolar RNAs called SNORD116, which may play a role in regulating gene expression in neurons. By using induced pluripotent stem cells (iPSCs) and neuronal derivatives, researchers aim to explore how activating the maternal copy of SNORD116 can help understand its function and potential therapeutic approaches. The research involves manipulating specific proteins to activate these genes and studying their effects on neuronal behavior.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing Prader-Willi syndrome.

How similar studies have gone: Previous research has shown promise in understanding genetic disorders through similar molecular approaches, indicating potential for success in this area.

Where this research is happening

  • University of Connecticut Sch of Med/dnt
    Farmington, United States
    Active

Researchers

  • Principal investigator: Carmichael, Gordon G — University of Connecticut Sch of Med/dnt
  • Study coordinator: Carmichael, Gordon G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.